학술논문
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study
Document Type
Artikel
Author
Source
Annals of the rheumatic diseases. 74(8):1567-1570
Subject
Language
English
English
English
ISSN
1468-2060